Article
Assessment of knowledge and attitudes of young uninsured women toward human papillomavirus vaccination and clinical trials
Registro en:
MOREIRA JUNIOR, E. D. et al. Assessment of knowledge and attitudes of young uninsured women toward human papillomavirus vaccination and clinical trials. Journal of Pediatric and Adolescent Gynecology, v.19, n.2, p. 81-87, 2006.
1083-3188
10.1016/j.jpag.2006.01.003
Autor
Moreira Júnior, Edson Duarte
Oliveira, Bruno Gusmão de
Neves, Raimundo Celestino Silva
Costa, Sandra
Karic, Gisela
Costa Filho, José Otávio
Resumen
Study Objective: To assess knowledge and attitudes
of young uninsured women toward human papillomavirus
(HPV) vaccination and clinical trials.
Design: Cross-sectional study.
Setting: Clinic-based sample in Brazil.
Participants: A consecutive sample of 204 women aged
16 to 23 years, attending a public outpatient gynecological
clinic.
Interventions: A questionnaire administered by in-person
interview.
Main Outcome Measures: Data on knowledge and attitudes
towards HPV vaccination.
Results: Overall, 72% of the respondents would enroll in
a HPV vaccine trial, despite the fact that 69% of women
were ignorant of what HPV may cause, and only 10% acknowledged
that HPV might lead to cervical cancer. The
need of a placebo arm (31%) and three vaccinations injections
(26%) were the trial design characteristics most cited
for deterring participation. Factors promoting participation
were ‘‘careful/detailed consultations by the same physician’’
(92%), ‘‘access to more information on women’s health’’
(84%), and ‘‘office visits on time’’ (79%); whereas ‘‘clinic
too far from home’’ (36%), ‘‘fear of adverse events’’
(29%), and ‘‘gynecologic examination discomfort’’ (25%)
were the most commonly reported reasons for not enrolling
in a trial. Being sexually active, more than three lifetime sexual
partners and perception of high risk for cervical cancer
were predictors of participation in a HPV vaccine trial.
Conclusions: Knowledge of HPV infection and cervical
cancer is low in this urban, young population. Thus, when
planning HPV vaccine trials, it is important to consider implementing
educational programs to provide knowledge of
the benefits of a preventive vaccine and information on
the etiology of and risk factors for cervical cancer.